The important finding was that AT-04 showed a moderate effect size, which was of a similar magnitude to that reported for duloxetine, although the primary endpoint of pain NRS did not reach statistical significance.
← all excerpts
Randomized Controlled Trial to Relieve Pain of Chemotherapy-Induced Peripheral Neuropathy by Magnetic Field: SMILE Study.
1
—
—